Effect of intake of oral carbamazepine and oral boswellia curcumin in pain reduction in Trigeminal Neuralgia patients

Evaluation of the efficacy of oral Carbamazepine therapy versus oral Carbamazepine Boswellia Curcumin combination therapy and oral Boswellia curcumin monotherapy in patients with Trigeminal Neuralgia A Randomized Controlled Trail

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/02/103085

Enrollment

Registered

2026-02-05

Start date

Unknown

Completion date

Unknown

Last updated

2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G440- Cluster headaches and other trigeminal autonomic cephalgias (TAC)

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients who were diagnosed with Trigeminal Neuralgia for the first time Patient willing to participate in the study and has the ability to complete the study

Exclusion criteria

Exclusion criteria: Patients who were previously diagnosed with Trigeminal Neuralgia Not willing to participate in the study Lactating or pregnant women Allergic, immunocompromised or systemic illness patients Asymptomatic patients

Design outcomes

Primary

Measure	Time frame
Tablet Boswellia Curcumin if found to be effective in patients with Trigeminal Neuralgia can be used as a single modality of treatment or as an adjunctive therapy in future in cases of Trigeminal NeuralgiaTimepoint: Tablet Boswellia Curcumin if found to be effective in patients with Trigeminal Neuralgia can be used as a single modality of treatment or as an adjunctive therapy in future in cases of Trigeminal Neuralgia Week 0,2,6,15 and 4 Months	—

Measure

Time frame

Tablet Boswellia Curcumin if found to be effective in patients with Trigeminal Neuralgia can be used as a single modality of treatment or as an adjunctive therapy in future in cases of Trigeminal NeuralgiaTimepoint: Tablet Boswellia Curcumin if found to be effective in patients with Trigeminal Neuralgia can be used as a single modality of treatment or as an adjunctive therapy in future in cases of Trigeminal Neuralgia Week 0,2,6,15 and 4 Months

—

Secondary

Measure	Time frame
NILTimepoint:	—

Countries

India

Contacts

Public ContactDr Khajal K

Tamilnadu Government Dental College and Hospital

dr.lkayal.kumar@gmail.com9445170282

Outcome results